Navigation Links
Neurological Wellness Center Physicians Group Asks CBS to Air the 60-Minute Show “A New Shot at Life” in the United States
Date:4/10/2013

(PRWEB) April 10, 2013

This 60 Minute show, which aired October 16, 2011, powerfully demonstrates that Alzheimer’s disease no longer has to be the long good-bye that it was for Ronald Reagan. Substantial recovery of memory and cognitive function is possible. One need only look into Charlie’s eyes to notice a striking transformation. Charlie himself said “It is like a miracle."

This show, “A New Shot at Life”, can be viewed online: http://sixtyminutes.ninemsn.com.au/stories/8360210/a-new-shot-at-life. Last year this show was rebroadcast in New Zealand. Neurological Wellness Center Physicians Augusto Ramirez, M.D., Meylin Acuna, M.D., Eugenia Siezar, M.D., and Rolando Rodriguez, M.D. call on CBS to rebroadcast this show in the United States.

The drug Enbrel, that enabled Charlie Giales to regain his mental faculties in this 60 Minutes episode, is used by over 400,000 Americans as a treatment for rheumatoid arthritis. However, for Enbrel to effectively treat Alzheimer’s, Stroke and TBI, it must be administered to the back of the neck precisely between cervical vertebrae C-5 and C-6.    

Since 2010 Neurological Wellness Center has been providing hands-on individual instruction on the administration of this perispinal injection at their headquarters in Managua Nicaragua. Visit reversealzheimersnow.com.

For many, flying to Managua Nicaragua to receive this personalized training is an enormous expense and inconvenience. To overcome this problem, Neurological Wellness Center, under the direction of Augusto Ramirez, M.D., created Perispinal Enbrel Step-By-Step Instructional Video and accompanying e-book. This 24-minute video and 25-page e-book are now available online at neurological-recovery-guide.com.

Augusto Ramirez, M.D., Director of Neurological Wellness Center, a private medical group in Managua Nicaragua, authorized this press release.

Presently all FDA-approved drugs for the treatment of Alzheimer’s disease simply slow the rate of disease progression. Enbrel, when administered to the area between cervical vertebrae C-5 and C-6, enables the recovery of cognitive function, reversing impairments to memory, resulting in an improved sense of well-being and more engaging social interaction. A portion of those people treated with perispinal Enbrel injections will go on to live normal lives and eventually die of causes unrelated to Alzheimer’s disease.

This 60 Minute episode clearly illustrates that rapid recovery of memory and cognitive functions is possible following a single perispinal injection of the drug Enbrel. There is a growing body of evidence that the impairments persons with Alzheimer’s disease experience are the result of the neuro-inflammatory response to the buildup of amyloid-beta plaques and tau proteins in the brain. TNF-alpha, a protein cytokine, is a central regulator of the human inflammatory response not only in the brain but throughout the body.

Excess TNF-alpha in the brain can disrupt synaptic communication. Excess TNF-alpha triggers a cycle whereby toxic amyloid-beta is produced. This results in greater levels of pro-inflammatory TNF-alpha. Etanercept (Enbrel) is a fusion of two proteins naturally occurring in the human body that was developed to treat various inflammatory diseases by binding to TNF-alpha, effectively neutralizing its ability to act on cell membranes. Enbrel treatment has a rapid effect, reversing cognitive impairment, and validating the role excess TNF-alpha has in the Alzheimer’s disease process. Enbrel’s long half-life (70 to 132 hours) enables a series of treatments to produce sequential progressive improvements in cognitive function that can be maintained long term. The standard method for delivering CNS-active medication to the brain is via the blood. Etanercept, a large protein molecule, is unable to cross the blood brain barrier. A subcutaneous perispinal injection to the fatty tissues at the back of the neck enables etanercept to enter the brain by lymph and venous drainage assisted by gravity.”

CBS 60 Minutes telephone: 212-975-3247
Address: 60 Minutes, 524 West 57th St., New York, NY 10019

For injections of Enbrel to be effective they must be administered to the soft fatty tissue in the back of the neck between cervical vertebrae C-5 and C-6. This simple subcutaneous injection, performed with a fine gauge ½ inch needle, is referred to as a perispinal injection. Neurological Wellness Center offers a complete two-hour course on Alzheimer's treatment, stroke treatment and traumatic brain injury treatment covering all aspects of perispinal injection technique at their center in Managua Nicaragua.

For many, flying to Neurological Wellness Center in Managua Nicaragua to receive this personalized training is an enormous expense and inconvenience. To overcome this problem, Neurological Wellness Center, under the direction of Augusto Ramirez, M.D., created Perispinal Enbrel Step-By-Step Instructional Video and accompanying e-book. This 24-minute video and 37-page e-book are now available online at http://www.neurological-recovery-guide.com.

Augusto Ramirez, M.D., Director of Neurological Wellness Center, a private medical group in Managua Nicaragua, authorized this press release.

Neurological Wellness Center’s perispinal Enbrel is profoundly effective as an Alzheimer's treatment with our Alzheimer's clinical trial, stroke treatment with our stroke clinical trial and as a TBI treatment. The complete treatment recommendation: for stroke is one 25mg injection of Enbrel every four days for a total of four doses over 16 days; for TBI is one 25mg injection of Enbrel every four days for a total of eight doses. This compares with Amgen/Pfizer’s FDA-approved dose schedule for moderate plaque psoriasis of 50mg twice weekly for three months followed by 50mg weekly for life. The Neurological Wellness Center’s maximum recommended dose for Alzheimer’s disease is 25mg/week for life.

The drug Enbrel is available now. Enbrel received FDA approval in 1998. Its safety profile is well understood. For Enbrel to effectively treat Alzheimer’s, stroke and TBI, it must be administered to the back of the neck precisely between the cervical vertebrae C-5 and C-6. This perispinal injection allows Enbrel to enter the brain by lymph drainage assisted by gravity. Fortunately for the millions of people now afflicted with Alzheimer’s, stroke and TBI, a video is now available online detailing in step-by-step fashion how to administer a perispinal injection of Enbrel,” said Dr. Rolando Rodrigues.

To enroll in a hands-on instructional course on perispinal injections visit http://www.reversealzheimersnow.com.

To purchase an instructional video and e-book on administering perispinal injections visit http://www.neurological-recovery-guide.com

To purchase Enbrel at the lowest prices in North America visit http://www.genuine-enbrel-cheaper.com/

Read the full story at http://www.prweb.com/releases/2013/4/prweb10525725.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Ivy Neurological Sciences Internship program funded at TGen
2. Kids With Neurological Conditions at Higher Risk of Flu Death: CDC
3. New national clinical trials network for neurological disorders to foster cutting-edge treatments
4. The hidden disorder: Unique treatment proposed for childrens neurological disorder
5. Cedars-Sinai physician-scientist awarded $3M to study most common inherited neurological disorder
6. University Hospitals Neurological Institute to present 6th International 2013 Epilepsy Colloquium
7. Neurological Wellness Center's Novel Neuro-Inflammation Inhibition Procedure that Induces Rapid Recovery from Alzheimer's, Stroke and Brain Injury is Now Being Taught in a Newly Released Video
8. Neurological Wellness Center Pays Tribute to Newly Released Study Announcing TBI Treatment Breakthrough
9. Neurological Wellness Center Posts 700% Sales Increase in 2012; Enters Strategic Alliance with Enbrel Buyer's Club to Provide Low Cost Enbrel
10. NIH clinical trial begins for treatment of rare, fatal neurological disorder
11. New technology may help doctors monitor concussions, aging, and neurological function
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2016)... ... February 05, 2016 , ... Give To Cure ... to search for and donate to Give To Cure’s campaign that is crowdfunding clinical ... lets users make and share payments through a smart device. In 2015 alone, Venmo ...
(Date:2/5/2016)... ... February 05, 2016 , ... At its annual meeting held ... as Chairman of the National Board of Directors. Mr. McDermott succeeds former APDA Chairman, ... stated Leslie A. Chambers , APDA President and CEO. “Pat has tirelessly served ...
(Date:2/5/2016)... Francisco, CA (PRWEB) , ... February 05, 2016 ... ... and founder of CitiDent, announces that it is now welcoming orthodontist, ... Dr. Cheng, CitiDent offers a complete range of oral health care, including general ...
(Date:2/5/2016)... ... ... Health and wellness is a topic that should concern all Americans; however, it ... illness. Migraines are a severe form of a headache and often are accompanied by ... pain on their worst enemy, the feeling can last for many hours and be ...
(Date:2/5/2016)... ... February 05, 2016 , ... Calls Blacklist has just been updated ... interface design and the developer has fixed known bugs within the app. Calls Blacklist ... their phone while not consuming any of their device’s battery power or memory. It ...
Breaking Medicine News(10 mins):
(Date:2/5/2016)... Calif. , Feb. 5, 2016 Amgen (NASDAQ: ... th Annual Global Healthcare Conference at 9:15 a.m. ET ... City . David W. Meline , executive vice ... the conference. Live audio of the presentation can be accessed ... under Investors. A replay of the webcast will also be ...
(Date:2/5/2016)... a medical devices company, is one of five recipients to ... Terry McAuliffe,s office. ivWatch will be receiving the STEM ... to be held at the Science Museum of ... that have made significant contributions to science. ... ivWatch ...
(Date:2/5/2016)... , Feb. 5, 2016  Aralez Pharmaceuticals Inc. ... of POZEN Inc. ("POZEN") and Tribute Pharmaceuticals Canada Inc. ("Tribute") ... and shareholders of Tribute. The combined company will operate ... company with operations in Canada , ... United States . Under the terms of the ...
Breaking Medicine Technology: